News
The firms will screen compounds from natural sources for activity against gene variants linked to chronic diseases.
SINGAPORE & WILMINGTON, Del.--(BUSINESS WIRE)--Nanyang Biologics (NYB) and Precisya Global Inc (PGI) announce a strategic collaboration to leverage our technologies in validating potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback